Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)Martin Stocker, FAM van den Dungen, Frank A B A Schuerman et al.|The Lancet|2017Cited by 266
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsÀngela Deyà‐Martínez, Manfred Fliegauf, Nils Klammer et al.|Journal of Allergy and Clinical Immunology|2020Cited by 127
C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention StudyMartin Stocker, Annemarie M. C. van Rossum, Wendy van Herk et al.|Clinical Infectious Diseases|2020Cited by 116